Catamaran receives PQA award for Medicare program
LISLE, Ill. — The Pharmacy Quality Alliance has given one of its top awards to pharmacy benefit manager Catamaran Corp., the PBM said Friday.
Catamaran announced that it received a 2013 PQA Quality Award recognizing its five-star rating on all PQA measures in the Part D Star Ratings program. The PQA’s stated goal is to improve patient health by championing clear performance measures for medication management, and the recognition program for prescription drug plans recognizes Medicare plans that have demonstrated outstanding performance in medication-related quality.
"We are honored to be recognized by PQA for our commitment to continuously enhancing the quality of care in the Medicare arena," Catamaran chairman and CEO Mark Thierer said. "By leveraging our resources, skill and scale, Catamaran has achieved powerful results in improving health outcomes and reducing costs, all with a laser-sharp focus on patient safety."
Actress Vanessa Williams announced as new Clear Eyes spokeswoman
TARRYTOWN, N.Y. — Clear Eyes announced this week that award-winning actress and singer Vanessa Williams is joining the brand as its new spokeswoman. Williams will star in a national advertising campaign, which will include several new television commercials that begin airing in June, and will also appear online in digital ads, on the Clear Eyes website and the brand’s Facebook page.
"As an actress I spend hours on stage under bright lights, reading scripts, sending emails and traveling on airplanes — conditions that create the perfect storm of dryness and irritation for my eyes," said Williams. "I always keep my Clear Eyes eye drops with me, so I can immediately soothe and moisturize my eyes. It provides instant and long-lasting relief from dryness, redness and whatever irritates my eyes."
"With her indisputably beautiful, crystal clear eyes and long-time advocacy for eye health, Vanessa is a natural fit for the Clear Eyes brand," said Tim Connors, chief marketing officer for Prestige Brands, Inc. "Her star power and influence will help the brand reach millions of consumers who suffer from eye irritation."
Even though about 60% of adults suffer from some type of eye irritation, only about 33% use eye drops. The new campaign will raise awareness of dry eye and other eye irritations, and highlight the efficacy of Clear Eyes over-the-counter eye drops, which provide fast-acting, multi-symptom relief and long-lasting comfort.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
Reports: Sun to buy Meda for up to $6 billion
NEW YORK — India-based Sun Pharmaceutical Industries may buy Sweden-based Meda for $5 billion to $6 billion, according to published reports.
Reuters reported that the two companies were in talks for Sun to buy Meda in order to boost its generics business in developed markets.
The news comes months after Sun and Taro terminated a merger agreement, a deal that Sun had been trying to secure since 2007. Several high-profile mergers among drug companies have occurred in the last few weeks, however, including Actavis’ announcement that it would buy Ireland-based Warner Chilcott for $8.5 billion and Valeant Pharmaceuticals International’s plans to buy Bausch & Lomb for $8.7 billion.